Vergelijking

Cetrorelix vs. Glepaglutide

Twee peptiden naast elkaar — identiteit, bewijsbasis, juridische status en bekende bijwerkingen.

Identiteit

Categorie

Onderzoek (overig)

CAS-nr.

120287-85-6

geen gegevens

Molecuulmassa

1431.06 g/mol

geen gegevens

Halfwaardetijd

geen gegevens

Sequentie

geen gegevens

Werkingsmechanisme

Cetrorelix

Cetrorelix competitively and immediately blocks the pituitary GnRH receptor, rapidly suppressing LH and FSH release — without the initial hormone surge ('flare') of GnRH agonists.

Glepaglutide

As a GLP-2 receptor agonist, glepaglutide has a trophic effect on the intestinal mucosa, enlarging the absorptive surface and thereby improving intestinal uptake of nutrients and fluid.

Bewijsbasis

Hoogste bewijs

Humane RCT

Studies

waarvan bij mensen

Geregistreerde effecten

Openstaande tegenstrijdigheden

Gedocumenteerde bijwerkingen

Juridische status

Country	Cetrorelix	Glepaglutide
Duitsland	Op recept	Niet goedgekeurd
Verenigde Staten	Op recept	Niet goedgekeurd

Volledige vermeldingen

Cetrorelix

Volledige vermelding →

Glepaglutide

Volledige vermelding →

Frequently asked questions

What is the difference between Cetrorelix and Glepaglutide?: Cetrorelix is classified as "Onderzoek (overig)", while Glepaglutide is classified as "Onderzoek (overig)". Cetrorelix: Cetrorelix is a synthetic decapeptide and GnRH antagonist. It is used in assisted reproduction (IVF) to prevent a premature LH surge during controlled ovarian stimulation. Glepaglutide: Glepaglutide is a long-acting GLP-2 analogue (Zealand Pharma) intended to reduce the need for parenteral support in short bowel syndrome. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
Which peptide is better supported by science, Cetrorelix or Glepaglutide?: The highest available evidence level is "Humane RCT" for Cetrorelix and "Humane RCT" for Glepaglutide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
What is the legal status of Cetrorelix and Glepaglutide in Germany and the United States?: Duitsland: Cetrorelix — Op recept, Glepaglutide — Niet goedgekeurd. Verenigde Staten: Cetrorelix — Op recept, Glepaglutide — Niet goedgekeurd. These are factual summaries with source and review date on the individual pages.

Country

Cetrorelix

Glepaglutide

Duitsland

Op recept

Niet goedgekeurd

Verenigde Staten

Op recept

Niet goedgekeurd

Frequently asked questions

What is the difference between Cetrorelix and Glepaglutide?

Cetrorelix is classified as "Onderzoek (overig)", while Glepaglutide is classified as "Onderzoek (overig)". Cetrorelix: Cetrorelix is a synthetic decapeptide and GnRH antagonist. It is used in assisted reproduction (IVF) to prevent a premature LH surge during controlled ovarian stimulation. Glepaglutide: Glepaglutide is a long-acting GLP-2 analogue (Zealand Pharma) intended to reduce the need for parenteral support in short bowel syndrome. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.

Which peptide is better supported by science, Cetrorelix or Glepaglutide?

The highest available evidence level is "Humane RCT" for Cetrorelix and "Humane RCT" for Glepaglutide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.

What is the legal status of Cetrorelix and Glepaglutide in Germany and the United States?

Duitsland: Cetrorelix — Op recept, Glepaglutide — Niet goedgekeurd. Verenigde Staten: Cetrorelix — Op recept, Glepaglutide — Niet goedgekeurd. These are factual summaries with source and review date on the individual pages.